In the medical decision making, the event of primary interest is recurrent, so that for a given unit the event could be observed more than once during the study. In general, the successive times between failures of human physiological systems are not necessarily identically distributed. However, if any critical deterioration is detected, then the decision of when to take the intervention, given the costs of diagnosis and therapeutics, is of fundamental importance. In this paper, Bayesian inference of a nonhomogeneous Poisson process with exponential failure intensity function is used to describe the behavior of aging physiological systems with aging chronic disease. In addition, we illustrate our method with an analysis of data from a trial...
International audienceThe Bayesian approach has been suggested as a suitable method in the context o...
The nonhomogeneous Poisson process is commonly used in the modeling of failure times of complex repa...
In this article, we propose a new Bayesian flexible cure rate survival model, which generalises the ...
The number of recurrent events before a terminating event is often of interest. For instance, death ...
In this article, the authors demonstrate a time-series analysis based on a hierarchical Bayesianmode...
In clinical and epidemiological studies, recurrent events occur frequently, such as such as repeated...
Risk modeling for recurrent cervical cancer requires the development of new concepts and metho-dolog...
There has been a recent surge of interest in modeling and methods for analyzing recurrent events dat...
The purpose of this paper is to develop a Bayesian analysis for the right-censored survival data whe...
The time duration in continuous time Bayesian networks, i.e., the time that a variable stays in a st...
We propose autoregressive Bayesian semi-parametric models for gap times between recurrent events. Th...
In this paper, we proposed a new two-parameter lifetime distribution with increasing failure rate. T...
This paper looks into the Bayesian approach for analyzing and selecting the best Poisson process mod...
Longitudinal data can be used to estimate the transition intensities between healthy and unhealthy s...
Abstract This article applies Bayesian reference analysis, widely considered as the most successful ...
International audienceThe Bayesian approach has been suggested as a suitable method in the context o...
The nonhomogeneous Poisson process is commonly used in the modeling of failure times of complex repa...
In this article, we propose a new Bayesian flexible cure rate survival model, which generalises the ...
The number of recurrent events before a terminating event is often of interest. For instance, death ...
In this article, the authors demonstrate a time-series analysis based on a hierarchical Bayesianmode...
In clinical and epidemiological studies, recurrent events occur frequently, such as such as repeated...
Risk modeling for recurrent cervical cancer requires the development of new concepts and metho-dolog...
There has been a recent surge of interest in modeling and methods for analyzing recurrent events dat...
The purpose of this paper is to develop a Bayesian analysis for the right-censored survival data whe...
The time duration in continuous time Bayesian networks, i.e., the time that a variable stays in a st...
We propose autoregressive Bayesian semi-parametric models for gap times between recurrent events. Th...
In this paper, we proposed a new two-parameter lifetime distribution with increasing failure rate. T...
This paper looks into the Bayesian approach for analyzing and selecting the best Poisson process mod...
Longitudinal data can be used to estimate the transition intensities between healthy and unhealthy s...
Abstract This article applies Bayesian reference analysis, widely considered as the most successful ...
International audienceThe Bayesian approach has been suggested as a suitable method in the context o...
The nonhomogeneous Poisson process is commonly used in the modeling of failure times of complex repa...
In this article, we propose a new Bayesian flexible cure rate survival model, which generalises the ...